When clinical trials become a normal part of care options for patients with unmet needs, both researchers and patients will reap exponential rewards. “Where are the patients?” Clinical trials hinge on recruitment, and enrollment issues are a perpetual challenge. Research estimates that, on average, around 20-25% of trials across all phases and therapeutic areas are […]
Read More
Dr. Adrian Liew, a nephrologist and scientific leader with George Clinical, was the recipient of the 2020 International Society for Peritoneal Dialysis Congress John Maher Award, honoring young individuals who have contributed substantially to the field of peritoneal dialysis (PD). Maher was a great contributor to the advancement of hemodialysis and peritoneal dialysis. He directed […]
Read MoreOVERLAND PARK, Ks., February 23, 2021 – David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based in Australia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter’s research focus is clinical and translational research in osteoarthritis (OA). He is the Florance and Cope Chair of […]
Read MoreThe COVID-19 pandemic continues to bring challenges to all of us on personal and professional levels but the importance of clinical research has perhaps never been higher. Our priority at George Clinical continues to be the safety and wellbeing of our employees, patients, investigators, clients and partners as we continue to execute critical studies in […]
Read More“Extraordinary achievements under unprecedented conditions,” is how Chief Medical Officer Maria Ali describes the reality of a George Clinical team drawing on proven working models, established global relationships and an unflinching dedication to implement a clinical trial in a matter of weeks during a global pandemic. Getting the job done despite extreme conditions The […]
Read MoreGeorge Clinical teams draw on proven working models, established global relationships and unflinching dedication to implement clinical trial in a matter of weeks. In the dark times of global COVID-19 lockdowns, scientists and healthcare workers pressed forward in their mission of caring for and protecting the sick, particularly those who were contracting COVID-19. The global […]
Read MoreOVERLAND PARK, Ks., January 15, 2021 – Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical […]
Read MoreRace Oncology announced recently that it has appointed George Clinical to scope and cost a proof-of-concept Phase I/II breast cancer clinical trial of Bisantrene in combination with cyclophosphamide. This program will enable the Race Oncology Board to make a fully informed and costed decision on this important clinical pathway before expending significant shareholder funds. Bisantrene […]
Read MoreGeorge Clinical team members recently participated in the 12th Annual DIA China Meeting, the largest Chinese event in the life sciences industry. The conference is designed to “foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies in the APAC region.” Around 3,000 pharmaceutical R&D professionals […]
Read MoreOVERLAND PARK, Ks., October 8, 2020 – Abby Abraham, a veteran clinical researcher and data science lead, has joined George Clinical, a global scientifically-backed clinical research organization, to head up the organization’s Global Data Science team and operations in India. Abraham, a progressive clinical research professional passionate about altering the existing clinical research execution paradigm […]
Read More
